Table 1 Anthropometric characteristics and duration of surgery in the three groups of patients (Group 30 mg, Group 40 mg, Group 50 mg of Chloroprocaine 1%). Data are expressed as median (range), mean ± SD and frequency (%) according to data distribution
FAS (45 patients) | |||
|---|---|---|---|
Dose Group | Chloroprocaine 1% | ||
Group 30 mg | Group 40 mg | Group 50 mg | |
Gender | |||
Female n (%) | 6 | 6 | 6 |
Male n (%) | 9 | 9 | 9 |
Age (years) | |||
Mean ± SD | 40.8 ± 12.1 | 39.4 ± 12.5 | 41.5 ± 13.9 |
Median (range) | 42 (22–58) | 41 (19–58) | 40 (10–63) |
Body weight (kg) | |||
Mean ± SD | 73.27 ± 14.11 | 70.27 ± 13.32 | 74.07 ± 13.14 |
Median (range) | 78 (47–99) | 66 (52–99) | 73 (48–98) |
Height (cm) | |||
Mean ± SD | 172 ± 6.9 | 170.2 ± 9.3 | 168.9 ± 7.1 |
Median (range) | 170 (158–185) | 173 (153–185) | 170 (153–180) |
BMI (kg/m2) | |||
Mean ± SD | 24.65 ± 3.96 | 24.19 ± 3.62 | 25.87 ± 3.71 |
Median (range) | 25.3 (18.8–30.6) | 22.2 (19.0–30.6) | 25.8 (18.3–31.3) |
Race | |||
Mestizo n (%) | 1 (6.7%) | 1 (6.7%) | 0 |
White n (%) | 14 (93.3%) | 14 (93.3%) | 15 (100%) |